Trial Watch: Adoptively transferred cells for anticancer immunotherapy
Sign Up to like & getrecommendations! Published in 2017 at "OncoImmunology"
DOI: 10.1080/2162402x.2017.1363139
Abstract: ABSTRACT Immunotherapies aimed at strengthening immune effector responses against malignant cells are growing at exponential rates. Alongside, the impressive benefits obtained by patients with advanced melanoma who received adoptively transferred tumor-infiltrating lymphocytes (TILs) have encouraged… read more here.
Keywords: trial watch; act; watch adoptively; adoptively transferred ... See more keywords
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
Sign Up to like & getrecommendations! Published in 2017 at "OncoImmunology"
DOI: 10.1080/2162402x.2017.1371896
Abstract: ABSTRACT The goal of cancer immunotherapy is to establish new or boost pre-existing anticancer immune responses that eradicate malignant cells while generating immunological memory to prevent disease relapse. Over the past few years, immunomodulatory monoclonal… read more here.
Keywords: immunostimulatory monoclonal; monoclonal antibodies; trial watch; watch immunostimulatory ... See more keywords
Trial watch: Immune checkpoint blockers for cancer therapy
Sign Up to like & getrecommendations! Published in 2017 at "OncoImmunology"
DOI: 10.1080/2162402x.2017.1373237
Abstract: ABSTRACT Immune checkpoint blockers (ICBs) are literally revolutionizing the clinical management of an ever more diversified panel of oncological indications. Although considerable attention persists around the inhibition of cytotoxic T lymphocyte-associated protein 4 (CTLA4) and… read more here.
Keywords: immune checkpoint; checkpoint blockers; watch immune; trial watch ... See more keywords
Trial watch: dendritic cell vaccination for cancer immunotherapy
Sign Up to like & getrecommendations! Published in 2019 at "OncoImmunology"
DOI: 10.1080/2162402x.2019.1638212
Abstract: ABSTRACT Dendritic- cells (DCs) have received considerable attention as potential targets for the development of anticancer vaccines. DC-based anticancer vaccination relies on patient-derived DCs pulsed with a source of tumor-associated antigens (TAAs) in the context… read more here.
Keywords: cell vaccination; dendritic cell; trial watch; vaccination ... See more keywords
Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Oncoimmunology"
DOI: 10.1080/2162402x.2022.2077898
Abstract: ABSTRACT The past decades witnessed the clinical employment of targeted therapies including but not limited to tyrosine kinase inhibitors (TKIs) that restrain a broad variety of pro-tumorigenic signals. TKIs can be categorized into (i) agents… read more here.
Keywords: inhibitors tkis; kinase inhibitors; tyrosine kinase; trial watch ... See more keywords
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Sign Up to like & getrecommendations! Published in 2022 at "Oncoimmunology"
DOI: 10.1080/2162402x.2022.2096363
Abstract: ABSTRACT Dendritic cell (DC)-based vaccination for cancer treatment has seen considerable development over recent decades. However, this field is currently in a state of flux toward niche-applications, owing to recent paradigm-shifts in immuno-oncology mobilized by… read more here.
Keywords: cell based; cell; based immunotherapy; dendritic cell ... See more keywords
Trial watch: Toll-like receptor ligands in cancer therapy
Sign Up to like & getrecommendations! Published in 2023 at "Oncoimmunology"
DOI: 10.1080/2162402x.2023.2180237
Abstract: ABSTRACT Accumulating evidence indicates that Toll-like receptor (TLR) agonists proficiently (re)instore cancer immunosurveillance as immunological adjuvants. So far, three TLR agonists have been approved by regulatory agencies for use in oncological applications. Additionally, these immunotherapeutics… read more here.
Keywords: toll like; tlr agonists; like receptor; cancer ... See more keywords
Transplant Trial Watch
Sign Up to like & getrecommendations! Published in 2021 at "Transplant International"
DOI: 10.1111/tri.13963
Abstract: To keep the transplantation community informed about recently published level 1 evidence in organ transplantation ESOT (https://esot.org/) and the Centre for Evidence in Transplantation have developed the Transplant Trial Watch (www.transplantevidence.com). The Transplant Trial Watch… read more here.
Keywords: trial watch; transplant trial; transplantation; evidence ... See more keywords
TRANSPLANT TRIAL WATCH
Sign Up to like & getrecommendations! Published in 2021 at "Transplant International"
DOI: 10.1111/tri.14017
Abstract: To keep the transplantation community informed about recently published level 1 evidence in organ transplantation ESOT (https://esot.org/) and the Centre for Evidence in Transplantation (www.transplantevidence.com) have developed the Transplant Trial Watch. The Transplant Trial Watch… read more here.
Keywords: trial watch; transplant trial; transplantation; watch transplant ... See more keywords
Transplant Trial Watch
Sign Up to like & getrecommendations! Published in 2021 at "Transplant International"
DOI: 10.3389/ti.2021.10216
Abstract: Citation: O’Callaghan JM (2022) Transplant Trial Watch. Transpl Int 35:10216. doi: 10.3389/ti.2021.10216 To keep the transplantation community informed about recently published level 1 evidence in organ transplantation ESOT and the Centre for Evidence in Transplantation… read more here.
Keywords: watch transplant; transplant trial; transplantation; trial watch ... See more keywords
Transplant Trial Watch
Sign Up to like & getrecommendations! Published in 2022 at "Transplant International"
DOI: 10.3389/ti.2022.10365
Abstract: by Hall, V. G., et al. New England Journal of Medicine 2021; 385 (13): 1244–1246. To keep the transplantation community informed about recently published level 1 evidence in organ transplantation ESOT and the Centre for… read more here.
Keywords: watch transplant; transplantation; transplant trial; trial watch ... See more keywords